Acumen Pharmaceuticals Inc (ABOS)
3.36
-0.21
(-5.88%)
USD |
NASDAQ |
May 10, 16:00
3.36
0.00 (0.00%)
After-Hours: 20:00
Acumen Pharmaceuticals Price to Book Value: 0.7561 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 10, 2024 | 0.7561 |
May 09, 2024 | 0.8034 |
May 08, 2024 | 0.7651 |
May 07, 2024 | 0.7561 |
May 06, 2024 | 0.8011 |
May 03, 2024 | 0.7854 |
May 02, 2024 | 0.7831 |
May 01, 2024 | 0.7314 |
April 30, 2024 | 0.7246 |
April 29, 2024 | 0.7156 |
April 26, 2024 | 0.7134 |
April 25, 2024 | 0.7179 |
April 24, 2024 | 0.7156 |
April 23, 2024 | 0.7111 |
April 22, 2024 | 0.7044 |
April 19, 2024 | 0.7089 |
April 18, 2024 | 0.7111 |
April 17, 2024 | 0.7809 |
April 16, 2024 | 0.7876 |
April 15, 2024 | 0.7944 |
April 12, 2024 | 0.8417 |
April 11, 2024 | 0.8754 |
April 10, 2024 | 0.8349 |
April 09, 2024 | 0.8642 |
April 08, 2024 | 0.8754 |
Date | Value |
---|---|
April 05, 2024 | 0.8664 |
April 04, 2024 | 0.8642 |
April 03, 2024 | 0.8799 |
April 02, 2024 | 0.8529 |
April 01, 2024 | 0.9024 |
March 28, 2024 | 0.9114 |
March 27, 2024 | 0.9227 |
March 26, 2024 | 0.8439 |
March 25, 2024 | 0.9564 |
March 22, 2024 | 0.9677 |
March 21, 2024 | 0.9744 |
March 20, 2024 | 0.9339 |
March 19, 2024 | 0.8677 |
March 18, 2024 | 0.8633 |
March 15, 2024 | 0.9067 |
March 14, 2024 | 0.8872 |
March 13, 2024 | 0.9436 |
March 12, 2024 | 0.8937 |
March 11, 2024 | 0.9284 |
March 08, 2024 | 0.9479 |
March 07, 2024 | 0.9479 |
March 06, 2024 | 0.9653 |
March 05, 2024 | 0.9436 |
March 04, 2024 | 0.9718 |
March 01, 2024 | 1.006 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3843
Minimum
Nov 09 2023
2.655
Maximum
Oct 05 2021
1.164
Average
1.042
Median
Feb 09 2022
Price to Book Value Benchmarks
Accuray Inc | 3.911 |
Kezar Life Sciences Inc | 0.2999 |
Akoya Biosciences Inc | 3.898 |
NovaBay Pharmaceuticals Inc | 1.774 |
Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
Price | 3.36 |
Earnings Yield | -32.44% |
Market Cap | 201.87M |